Trials / Not Yet Recruiting
Not Yet RecruitingNCT06462950
Experiment Among Smokers in Which Two Variables Are Manipulated: Ostracism and Concealability
Study 3: The Experimental Examination of Ostracism and Concealability on Gendered Stigma Smoking Outcomes
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 340 (estimated)
- Sponsor
- Dickinson College · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this experimental study is to learn about the effects of ostracism and concealment among adult smokers. The main aims are: 1. Determine the causal consequences of gendered stigmatization. Specifically, do women react more strongly than men to exclusion (as opposed to inclusion) especially when their gender is revealed (as opposed to concealed) for outcomes such as smoking stigma, stress, cognitive depletion, smoking attitudes, and smoking cessation intentions (Study 3)? 2. Examine the moderating roles of cultural context. Specifically, contrasting the cultural context in the US and Denmark (where gender norms are more egalitarian) do Danish smokers show fewer gender differences than US smokers in how they describe and react to their smoking stigmatization experiences (Study 1, 2, and 3)?
Detailed description
The proposed studies examine cross-culturally the reasons why among smokers, women feel more stigmatized than men do. An experiment with US and Danish smokers will examine how men and women differ in their reactions to being stigmatized (using a standard exclusion manipulation) when their gender is revealed instead of concealed. The outcome measures will include stress, smoking stigma, cognitive depletion, smoking attitudes, and smoking cessation intentions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Do men and women differ in their reactions to the experimental conditions. | Do men and women differ in their reactions to the experimental conditions. |
Timeline
- Start date
- 2028-05-01
- Primary completion
- 2028-07-01
- Completion
- 2028-12-01
- First posted
- 2024-06-17
- Last updated
- 2024-06-17
Source: ClinicalTrials.gov record NCT06462950. Inclusion in this directory is not an endorsement.